Zhengye Biotechnology Holding (ZYBT) Short term Debt (2023 - 2024)
Zhengye Biotechnology Holding (ZYBT) has disclosed Short term Debt for 2 consecutive years, with $1.0 million as the latest value for Q4 2024.
- Quarterly Short term Debt fell 90.98% to $1.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2024, down 90.98% year-over-year, with the annual reading at $10.2 million for FY2024, 9.75% down from the prior year.
- Short term Debt for Q4 2024 was $1.0 million at Zhengye Biotechnology Holding, down from $11.1 million in the prior quarter.
- The five-year high for Short term Debt was $11.1 million in Q4 2023, with the low at $1.0 million in Q4 2024.